Spots Global Cancer Trial Database for esophagogastric adenocarcinoma
Every month we try and update this database with for esophagogastric adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study Evaluating Treatment of Sacituzumab-govitecan for Patients With Metastatic Esophagogastric Adenocarcinoma | NCT06123468 | Esophagogastric... | Sacituzumab gov... | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma | NCT03193918 | Esophagogastric... | Crenolanib Ramucirumab Paclitaxel | 18 Years - | Arog Pharmaceuticals, Inc. | |
| Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric Adenocarcinoma | NCT03193918 | Esophagogastric... | Crenolanib Ramucirumab Paclitaxel | 18 Years - | Arog Pharmaceuticals, Inc. | |
| Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | NCT01769508 | HER2 Positive E... | 5-Fluorouracil Oxaliplatin Lapatinib Radiation Thera... | 18 Years - | SCRI Development Innovations, LLC | |
| Nintedanib in Patients With Advanced Esophagogastric Cancer | NCT02234596 | Esophagogastric... | Nintedanib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma | NCT05504720 | Esophagogastric... | Pembrolizumab Trastuzumab FLOT | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | NCT01769508 | HER2 Positive E... | 5-Fluorouracil Oxaliplatin Lapatinib Radiation Thera... | 18 Years - | SCRI Development Innovations, LLC | |
| Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma | NCT03921021 | Esophagogastric... | Telomelysin | 18 Years - | Weill Medical College of Cornell University | |
| Nintedanib Plus mFOLFOX6 for Previously Untreated Metastatic Esophagogastric Adenocarcinoma (MEGAN) | NCT02856867 | Esophagogastric... Metastatic Dise... No Previous Che... | Nintedanib Fluorouracil Leucovorin Oxaliplatin Placebo | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | NCT05268510 | Esophagogastric... | Pembrolizumab Olaparib mFOLFOX-6 CapOX | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Nintedanib in Patients With Advanced Esophagogastric Cancer | NCT02234596 | Esophagogastric... | Nintedanib | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Molecular Characteristics of Gastroesophageal Adenocarcinoma (MOCHA): A Prospective Feasibility Study | NCT04219137 | Esophagogastric... | Molecular Profi... | 18 Years - | University Health Network, Toronto |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
